Phreesia, Inc. (PHR) – What Are Analysts Thinking About This Stock?

Phreesia, Inc. (NYSE:PHR) has earned an average recommendation of “Hold” from the nineteen ratings firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eight have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $14.07.

A number of equities research analysts recently commented on the stock. Needham & Company LLC reiterated a “buy” rating and set a $14.00 price target on shares of Phreesia in a report on Monday, August 31st. Barclays boosted their price objective on shares of Phreesia from $10.00 to $11.00 and gave the company an “equal weight” rating in a research report on Monday, October 12th. Weiss Ratings upgraded shares of Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday, October 19th. DA Davidson cut their target price on Phreesia from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, September 4th. Finally, Raymond James Financial cut Phreesia from an “outperform” rating to a “market perform” rating in a research note on Tuesday, September 8th.

Insiders Place Their Bets

In other Phreesia news, General Counsel Allison C. Hoffman sold 6,662 shares of the stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $10.08, for a total value of $67,152.96. Following the completion of the sale, the general counsel owned 266,574 shares in the company, valued at approximately $2,687,065.92. This trade represents a 2.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 5.20% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in PHR. EverSource Wealth Advisors LLC boosted its holdings in Phreesia by 1,119.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock valued at $27,000 after acquiring an additional 3,001 shares in the last quarter. New York State Teachers Retirement System purchased a new position in Phreesia during the 1st quarter valued at $44,000. Rockefeller Capital Management L.P. raised its holdings in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after purchasing an additional 2,149 shares in the last quarter. Allworth Financial LP bought a new position in Phreesia in the 2nd quarter worth $58,000. Finally, Essential Partners LLC lifted its position in shares of Phreesia by 2,016.6% in the 1st quarter. Essential Partners LLC now owns 9,313 shares of the company’s stock worth $78,000 after purchasing an additional 8,873 shares during the period. Institutional investors own 92.10% of the company’s stock.

Phreesia Price Performance

Shares of Phreesia stock opened at $12.27 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.76 and a quick ratio of 1.76. The business’s 50 day simple moving average is $11.06 and its two-hundred day simple moving average is $10.95. The stock has a market capitalization of $761.72 million, a P/E ratio of 41.47 and a beta of 0.75. Phreesia has a one year low of $7.77 and a one year high of $23.31.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The company had revenue of $129.46 million during the quarter, compared to the consensus estimate of $129.06 million. During the same quarter in the previous year, the firm posted $0.01 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Analysts forecast that Phreesia will post 0.33 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides a platform for managing administrative and financial interactions between healthcare organizations and their patients. Its software is designed to help medical practices and other care providers streamline registration, intake, payments, communications and related workflows.

The Phreesia platform includes digital patient check-in tools that allow patients to complete forms, update demographic and insurance information, make payments and review relevant educational or administrative content.